We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
-6.42%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.49B
AUM Growth
-$229M
Cap. Flow
-$115M
Cap. Flow %
-7.69%
Top 10 Hldgs %
22.33%
Holding
2,451
New
741
Increased
498
Reduced
386
Closed
708

Top Buys

Rank Stock Value
1
RHT
Red Hat Inc
RHT
+$30M
2
TVPT
Travelport Worldwide Limited
TVPT
+$20M
3
IMPV
Imperva, Inc.
IMPV
+$19M
4
ATHN
Athenahealth, Inc.
ATHN
+$16M
5
IDTI
Integrated Device Technology I
IDTI
+$13.9M

Top Sells

Rank Stock Value
1
AET
Aetna Inc
AET
+$48.3M
2
COL
Rockwell Collins
COL
+$34.6M
3
DELL icon
Dell
DELL
+$33.7M
4
CA
CA, Inc.
CA
+$33.7M
5
NXPI icon
NXP Semiconductors
NXPI
+$23.7M

Sector Composition

Rank Sector Weight
1 Technology 11.52%
2 Communication Services 10.15%
3 Healthcare 7.28%
4 Consumer Discretionary 5.72%
5 Financials 4.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WGO icon
1676
Winnebago Industries
WGO
$909M
$2K ﹤0.01%
+79
New +$2.09K
WT icon
1677
WisdomTree
WT
$3.22B
$2K ﹤0.01%
+365
New +$2.65K
HT
1678
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
$2K ﹤0.01%
+121
New +$2.26K
MCRN
1679
DELISTED
Milacron Holdings Corp.
MCRN
$2K ﹤0.01%
+128
New +$1.92K
INSY
1680
DELISTED
Insys Therapeutics, Inc.
INSY
$2K ﹤0.01%
486
– –
ZGNX
1681
DELISTED
Zogenix, Inc.
ZGNX
$2K ﹤0.01%
54
-1,246
-96% -$51K
ABEO icon
1682
Abeona Therapeutics
ABEO
$413M
$1K ﹤0.01%
6
-81
-93% -$17.7K
OSG
1683
Octave Specialty Group
OSG
$222M
$1K ﹤0.01%
+59
New +$1.08K
AQST icon
1684
Aquestive Therapeutics
AQST
$494M
$1K ﹤0.01%
+201
New +$2.54K
AXDX
1685
CALL
DELISTED
Accelerate Diagnostics
AXDX
$1K ﹤0.01%
+10
New +$1.48K
CMT icon
1686
Core Molding Technologies
CMT
$234M
$1K ﹤0.01%
112
-5,476
-98% -$39.5K
CTSO icon
1687
Cytosorbents Corp
CTSO
$22.6M
$1K ﹤0.01%
136
-1,320
-91% -$13.1K
CYTK icon
1688
Cytokinetics
CYTK
$10.4B
$1K ﹤0.01%
+215
New +$1.58K
DXR icon
1689
Daxor
DXR
$59M
$1K ﹤0.01%
+157
New +$1.02K
FBRX icon
1690
Forte Biosciences
FBRX
$1.57B
– –
0
– –
FCNCA icon
1691
First Citizens BancShares
FCNCA
$25.3B
$1K ﹤0.01%
+3
New +$1.26K
FRPT icon
1692
Freshpet
FRPT
$3.22B
$1K ﹤0.01%
+20
New +$696
LADR
1693
Ladder Capital
LADR
$1.24B
$1K ﹤0.01%
96
-385
-80% -$6.54K
ORA icon
1694
Ormat Technologies
ORA
$6.65B
$1K ﹤0.01%
+26
New +$1.37K
RGP icon
1695
Resources Connection
RGP
$145M
$1K ﹤0.01%
103
-1,156
-92% -$18.7K
SJM icon
1696
J.M. Smucker
SJM
$12.8B
$1K ﹤0.01%
14
-1,304
-99% -$136K
TXMD icon
1697
TherapeuticsMD
TXMD
$24M
$1K ﹤0.01%
+4
New +$976
UVE icon
1698
Universal Insurance Holdings
UVE
$1.23B
$1K ﹤0.01%
+35
New +$1.52K
VMI icon
1699
Valmont Industries
VMI
$9.53B
$1K ﹤0.01%
+13
New +$1.62K
VYGR icon
1700
Voyager Therapeutics
VYGR
$201M
$1K ﹤0.01%
157
+116
+283% +$1.49K
66 67
68
69 70

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Prelude Capital Management held 2,451 positions worth $1.49B, down 13% from $1.72B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Prelude Capital Management withdrew a net $115M in Q4 2018, closing 708 positions and reducing 386 holdings. Its most notable exit was Aetna Inc, an estimated $48.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 15% a quarter earlier, followed by Communication Services and Healthcare.

Against the trend, Prelude Capital Management opened a new position in Red Hat Inc worth $33.2M.

  • Prelude Capital Management's largest Q4 2018 buy was Red Hat Inc: 189,248 shares worth $33.2M.
  • Prelude Capital Management added most to Athenahealth, Inc. in Q4 2018, an estimated $16M increase.
  • Prelude Capital Management's biggest Q4 2018 reduction was Dell, cutting an estimated $33.7M.
  • Prelude Capital Management fully exited Aetna Inc in Q4 2018, selling an estimated $48.3M.
  • Prelude Capital Management's ten largest holdings make up 22% of its $1.49B portfolio in Q4 2018.
  • Prelude Capital Management opened 741 new positions and closed 708 in Q4 2018.
  • Prelude Capital Management's portfolio value fell 13% quarter-over-quarter to $1.49B.

Based on Prelude Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.